South Africa Pharmaceutical Manufacturing Market Size & Outlook
The pharmaceutical manufacturing market in South Africa is expected to reach a projected revenue of US$ 3,517.0 million by 2030. A compound annual growth rate of 8.9% is expected of South Africa pharmaceutical manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,939.3
Forecast, 2030 (US$M)
$3,517.0
CAGR, 2024 - 2030
8.9%
Report Coverage
South Africa
Global Market
Related Markets
South Africa pharmaceutical manufacturing market highlights
- The South Africa pharmaceutical manufacturing market generated a revenue of USD 1,939.3 million in 2023 and is expected to reach USD 3,517.0 million by 2030.
- The South Africa market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule type in 2023.
- Conventional Drugs (Small Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Pharmaceutical manufacturing market data book summary
| Market revenue in 2023 | USD 1,939.3 million |
| Market revenue in 2030 | USD 3,517.0 million |
| Growth rate | 8.9% (CAGR from 2024 to 2030) |
| Largest segment | Conventional drugs (small molecules) |
| Fastest growing segment | Conventional Drugs (Small Molecules) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
| Key market players worldwide | Roche Holding AG ADR, Novartis AG ADR, GlaxoSmithKline, Pfizer Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson, Sanofi SA, Eli Lilly and Co, AbbVie Inc, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Samsung BioLogics, FUJIFILM Holdings Corp, Lonza Group Ltd, Catalent Inc, Jubilant Pharmova |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.4% of the global pharmaceutical manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa pharmaceutical manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 3,517.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Pharmaceutical Manufacturing Market Scope
Pharmaceutical Manufacturing Market segmentation & scope
Pharmaceutical Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
South Africa Pharmaceutical Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Pharmaceutical Manufacturing Market Outlook will help companies and investors design strategic landscapes.
Conventional Drugs (Small Molecules) was the largest segment with a revenue share of 52.54% in 2023.
Horizon Databook has segmented the South Africa pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
- South Africa Pharmaceutical Manufacturing Market Molecule Type Outlook (Revenue, USD Million , 2018-2030)
- Biologics & Biosimilars (Large Molecules)
- Conventional Drugs (Small Molecules)
- South Africa Pharmaceutical Manufacturing Market Drug Development Type Outlook (Revenue, USD Million , 2018-2030)
- Outsource
- In-house
- South Africa Pharmaceutical Manufacturing Market Formulation Outlook (Revenue, USD Million , 2018-2030)
- Tablets
- Capsules
- Injectables
- Sprays
- Suspensions
- Powders
- Other Formulations
- South Africa Pharmaceutical Manufacturing Market Routes of Administration Outlook (Revenue, USD Million , 2018-2030)
- Oral
- Topical
- Parenterals
- Inhalations
- Other Routes of Administration
- South Africa Pharmaceutical Manufacturing Market Therapy Area Outlook (Revenue, USD Million , 2018-2030)
- Cardiovascular Diseases
- Pain
- Diabetes
- Cancer
- Respiratory Diseases
- Other Diseases
- South Africa Pharmaceutical Manufacturing Market Prescription Requirements Outlook (Revenue, USD Million , 2018-2030)
- Prescription Medicines
- Over-the-counter (OTC) Medicines
- South Africa Pharmaceutical Manufacturing Market Age Type Outlook (Revenue, USD Million , 2018-2030)
- Children & Adolescents
- Adults
- Geriatric
- South Africa Pharmaceutical Manufacturing Market Sales Channel Outlook (Revenue, USD Million , 2018-2030)
- Retail
- Non-retail
Reasons to subscribe to Pharmaceutical Manufacturing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Pharmaceutical Manufacturing Market Outlook databook
- Our clientele includes a mix of Pharmaceutical Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa Pharmaceutical Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Africa Pharmaceutical Manufacturing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
South Africa Pharmaceutical Manufacturing Market, 2018-2030 (US$M)
South Africa pharmaceutical manufacturing market statistics, by molecule type, 2018-2030 (US$M)
